{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T03:35:54Z","timestamp":1776137754191,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Stanford Neurosurgery Equity Seed Grant"},{"name":"Arkadi Hulman Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s11060-022-04031-6","type":"journal-article","created":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T13:04:22Z","timestamp":1653138262000},"page":"445-451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Impact of socio-economic factors on radiation treatment after resection of metastatic brain tumors: trends from a private insurance database"],"prefix":"10.1007","volume":"158","author":[{"given":"David Y. A.","family":"Dadey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghani","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erqi L.","family":"Pollom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anand","family":"Veeravagu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"4031_CR1","doi-asserted-by":"publisher","first-page":"e797","DOI":"10.1016\/j.wneu.2020.09.085","volume":"144","author":"AL Chin","year":"2020","unstructured":"Chin AL, Li G, Gephart MH et al (2020) Stereotactic radiosurgery after resection of brain metastases: changing patterns of care in the United States. World Neurosurg 144:e797\u2013e806. https:\/\/doi.org\/10.1016\/j.wneu.2020.09.085","journal-title":"World Neurosurg"},{"key":"4031_CR2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jocn.2017.08.028","volume":"45","author":"DM Trifiletti","year":"2017","unstructured":"Trifiletti DM, Sheehan JP, Grover S et al (2017) National trends in radiotherapy for brain metastases at time of diagnosis of non-small cell lung cancer. J Clin Neurosci 45:48\u201353. https:\/\/doi.org\/10.1016\/j.jocn.2017.08.028","journal-title":"J Clin Neurosci"},{"issue":"11","key":"4031_CR3","doi-asserted-by":"publisher","first-page":"12318","DOI":"10.18632\/oncotarget.7131","volume":"7","author":"H Soliman","year":"2016","unstructured":"Soliman H, Das S, Larson DA, Sahgal A (2016) Stereotactic radiosurgery (SRS) in the modern management of patients with brain metastases. Oncotarget 7(11):12318\u201312330. https:\/\/doi.org\/10.18632\/oncotarget.7131","journal-title":"Oncotarget"},{"issue":"6","key":"4031_CR4","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.3171\/2018.8.Jns181599","volume":"131","author":"JP Sheehan","year":"2018","unstructured":"Sheehan JP, Grills I, Chiang VL et al (2018) Quality of life outcomes for brain metastasis patients treated with stereotactic radiosurgery: pre-procedural predictive factors from a prospective national registry. J Neurosurg 131(6):1848\u20131854. https:\/\/doi.org\/10.3171\/2018.8.Jns181599","journal-title":"J Neurosurg"},{"issue":"11","key":"4031_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/s1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037\u20131044. https:\/\/doi.org\/10.1016\/s1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"key":"4031_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000493055","volume":"34","author":"A Niranjan","year":"2019","unstructured":"Niranjan A, Monaco E, Flickinger J, Lunsford LD (2019) Guidelines for multiple brain metastases radiosurgery. Prog Neurol Surg 34:100\u2013109. https:\/\/doi.org\/10.1159\/000493055","journal-title":"Prog Neurol Surg"},{"issue":"2","key":"4031_CR7","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/jco.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(2):134\u2013141. https:\/\/doi.org\/10.1200\/jco.2010.30.1655","journal-title":"J Clin Oncol"},{"issue":"6","key":"4031_CR8","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.3171\/2020.4.Jns20788","volume":"134","author":"A Bunevicius","year":"2020","unstructured":"Bunevicius A, Lavezzo K, Shabo L, McClure J, Sheehan JP (2020) Quality-of-life trajectories after stereotactic radiosurgery for brain metastases. J Neurosurg 134(6):1791\u20131799. https:\/\/doi.org\/10.3171\/2020.4.Jns20788","journal-title":"J Neurosurg"},{"issue":"3","key":"4031_CR9","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ijrobp.2017.08.024","volume":"100","author":"G Minniti","year":"2018","unstructured":"Minniti G, Soltys SG, Halasz LM et al (2018) Stereotactic radiosurgery for resected brain metastases: new evidence supports a practice shift, but questions remain. Int J Radiat Oncol Biol Phys 100(3):535\u2013538. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.08.024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4031_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.ijrobp.2019.11.022","volume":"106","author":"S Shi","year":"2020","unstructured":"Shi S, Sandhu N, Jin MC et al (2020) Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities. Int J Radiat Oncol Biol Phys 106(4):764\u2013771. https:\/\/doi.org\/10.1016\/j.ijrobp.2019.11.022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4031_CR11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ijrobp.2007.06.068","volume":"70","author":"SG Soltys","year":"2008","unstructured":"Soltys SG, Adler JR, Lipani JD et al (2008) Stereotactic radiosurgery of the postoperative resection cavity for brain metastases. Int J Radiat Oncol Biol Phys 70(1):187\u2013193. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.06.068","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4031_CR12","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jama.2016.9839","volume":"316","author":"PD Brown","year":"2016","unstructured":"Brown PD, Jaeckle K, Ballman KV et al (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316(4):401\u2013409. https:\/\/doi.org\/10.1001\/jama.2016.9839","journal-title":"JAMA"},{"issue":"21","key":"4031_CR13","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1001\/jama.295.21.2483","volume":"295","author":"H Aoyama","year":"2006","unstructured":"Aoyama H, Shirato H, Tago M et al (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295(21):2483\u20132491. https:\/\/doi.org\/10.1001\/jama.295.21.2483","journal-title":"JAMA"},{"issue":"3","key":"4031_CR14","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1093\/neuros\/nyaa075","volume":"87","author":"NM Warsi","year":"2020","unstructured":"Warsi NM, Karmur BS, Brar K et al (2020) The role of stereotactic radiosurgery in the management of brain metastases from a health-economic perspective: a systematic review. Neurosurgery 87(3):484\u2013497. https:\/\/doi.org\/10.1093\/neuros\/nyaa075","journal-title":"Neurosurgery"},{"issue":"12","key":"4031_CR15","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.6004\/jnccn.2017.7003","volume":"15","author":"BH Kann","year":"2017","unstructured":"Kann BH, Park HS, Johnson SB, Chiang VL, Yu JB (2017) Radiosurgery for brain metastases: changing practice patterns and disparities in the United States. J Natl Compr Canc Netw 15(12):1494\u20131502. https:\/\/doi.org\/10.6004\/jnccn.2017.7003","journal-title":"J Natl Compr Canc Netw"},{"key":"4031_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2020.101792","volume":"68","author":"RR De la Garza","year":"2020","unstructured":"De la Garza RR, Benton JA, Gelfand Y et al (2020) Racial disparities in clinical presentation, type of intervention, and in-hospital outcomes of patients with metastatic spine disease: an analysis of 145,809 admissions in the United States. Cancer Epidemiol 68:101792. https:\/\/doi.org\/10.1016\/j.canep.2020.101792","journal-title":"Cancer Epidemiol"},{"key":"4031_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2021.7.Spine21287","volume":"5","author":"B Hung","year":"2021","unstructured":"Hung B, Pennington Z, Hersh AM et al (2021) Impact of race on nonroutine discharge, length of stay, and postoperative complications after surgery for spinal metastases. J Neurosurg Spine 5:1\u20138. https:\/\/doi.org\/10.3171\/2021.7.Spine21287","journal-title":"J Neurosurg Spine"},{"issue":"5","key":"4031_CR18","doi-asserted-by":"publisher","first-page":"617","DOI":"10.14444\/5076","volume":"12","author":"GW Poorman","year":"2018","unstructured":"Poorman GW, Moon JY, Wang C et al (2018) Rates of mortality in lumbar spine surgery and factors associated with its occurrence over a 10-year period: a study of 803,949 patients in the nationwide inpatient sample. Int J Spine Surg 12(5):617\u2013623. https:\/\/doi.org\/10.14444\/5076","journal-title":"Int J Spine Surg"},{"issue":"8","key":"4031_CR19","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"issue":"8","key":"4031_CR20","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"issue":"Suppl 1","key":"4031_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3171\/2016.7.GKS161499","volume":"125","author":"NH Lester-Coll","year":"2016","unstructured":"Lester-Coll NH, Dosoretz AP, Magnuson WJ, Laurans MS, Chiang VL, Yu JB (2016) Cost-effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for up to 10 brain metastases. J Neurosurg 125(Suppl 1):18\u201325. https:\/\/doi.org\/10.3171\/2016.7.GKS161499","journal-title":"J Neurosurg"},{"issue":"1","key":"4031_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10585-019-10005-2","volume":"37","author":"MS Ascha","year":"2020","unstructured":"Ascha MS, Funk K, Sloan AE, Kruchko C, Barnholtz-Sloan JS (2020) Disparities in the use of stereotactic radiosurgery for the treatment of lung cancer brain metastases: a SEER-Medicare study. Clin Exp Metastasis 37(1):85\u201393. https:\/\/doi.org\/10.1007\/s10585-019-10005-2","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"4031_CR23","doi-asserted-by":"publisher","first-page":"e4031","DOI":"10.7759\/cureus.4031","volume":"11","author":"A Modh","year":"2019","unstructured":"Modh A, Doshi A, Burmeister C, Elshaikh MA, Lee I, Shah M (2019) Disparities in the use of single-fraction stereotactic radiosurgery for the treatment of brain metastases from non-small cell lung cancer. Cureus 11(2):e4031. https:\/\/doi.org\/10.7759\/cureus.4031","journal-title":"Cureus"},{"issue":"2","key":"4031_CR24","doi-asserted-by":"publisher","first-page":"e109","DOI":"10.1016\/j.ijrobp.2012.08.007","volume":"85","author":"LM Halasz","year":"2013","unstructured":"Halasz LM, Weeks JC, Neville BA, Taback N, Punglia RS (2013) Use of stereotactic radiosurgery for brain metastases from non-small cell lung cancer in the United States. Int J Radiat Oncol Biol Phys 85(2):e109\u2013e116. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.08.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4031_CR25","doi-asserted-by":"publisher","first-page":"e935","DOI":"10.1016\/j.clgc.2018.03.015","volume":"16","author":"W Haque","year":"2018","unstructured":"Haque W, Verma V, Butler EB, Teh BS (2018) Utilization of stereotactic radiosurgery for renal cell carcinoma brain metastases. Clin Genitourin Cancer 16(4):e935\u2013e943. https:\/\/doi.org\/10.1016\/j.clgc.2018.03.015","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"4031_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctrv.2013.05.002","volume":"40","author":"B Lippitz","year":"2014","unstructured":"Lippitz B, Lindquist C, Paddick I, Peterson D, O\u2019Neill K, Beaney R (2014) Stereotactic radiosurgery in the treatment of brain metastases: the current evidence. Cancer Treat Rev 40(1):48\u201359. https:\/\/doi.org\/10.1016\/j.ctrv.2013.05.002","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4031_CR27","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/0825859720982204","volume":"36","author":"E Kim","year":"2021","unstructured":"Kim E, McClelland S 3rd, Jaboin JJ, Attia A (2021) Disparities in patterns of conventional versus stereotactic body radiotherapy in the treatment of spine metastasis in the United States. J Palliat Care 36(2):130\u2013134. https:\/\/doi.org\/10.1177\/0825859720982204","journal-title":"J Palliat Care"},{"key":"4031_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2021.12.007","author":"MB Mazor","year":"2022","unstructured":"Mazor MB, Li L, Morillo J, Allen OS, Wisnivesky JP, Smith CB (2022) Disparities in supportive care needs over time between racial and ethnic minority and non-minority patients with advanced lung cancer. J Pain Symptom Manage. https:\/\/doi.org\/10.1016\/j.jpainsymman.2021.12.007","journal-title":"J Pain Symptom Manage"},{"issue":"2","key":"4031_CR29","doi-asserted-by":"publisher","first-page":"e343","DOI":"10.1016\/j.clbc.2018.11.001","volume":"19","author":"W Mainwaring","year":"2019","unstructured":"Mainwaring W, Bowers J, Pham N et al (2019) Stereotactic radiosurgery versus whole brain radiation therapy: a propensity score analysis and predictors of care for patients with brain metastases from breast cancer. Clin Breast Cancer 19(2):e343\u2013e351. https:\/\/doi.org\/10.1016\/j.clbc.2018.11.001","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"4031_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.adro.2017.07.002","volume":"2","author":"S McClelland 3rd","year":"2017","unstructured":"McClelland S 3rd, Page BR, Jaboin JJ, Chapman CH, Deville C Jr, Thomas CR Jr (2017) The pervasive crisis of diminishing radiation therapy access for vulnerable populations in the United States, part 1: African-American patients. Adv Radiat Oncol 2(4):523\u2013531. https:\/\/doi.org\/10.1016\/j.adro.2017.07.002","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"4031_CR31","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21338","volume":"14","author":"HA Beydoun","year":"2022","unstructured":"Beydoun HA, Huang S, Beydoun MA, Eid SM, Zonderman AB (2022) Interrupted time-series analysis of stereotactic radiosurgery for brain metastases before and after the affordable care act. Cureus 14(1):e21338. https:\/\/doi.org\/10.7759\/cureus.21338","journal-title":"Cureus"},{"issue":"1","key":"4031_CR32","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-019-03283-z","volume":"145","author":"S McClelland 3rd","year":"2019","unstructured":"McClelland S 3rd, Degnin C, Chen Y, Watson GA, Jaboin JJ (2019) Impact of the American tax payer relief act on stereotactic radiosurgery utilization in the united States. J Neurooncol 145(1):159\u2013165. https:\/\/doi.org\/10.1007\/s11060-019-03283-z","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-022-04031-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-022-04031-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T13:21:22Z","timestamp":1657027282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-022-04031-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["4031"],"URL":"https:\/\/doi.org\/10.1007\/s11060-022-04031-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,21]]},"assertion":[{"value":"26 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"John Adler, MD is an employee of Zap Surgical Systems Inc. Erqi L. Pollom, MD, MS is on the advocacy board for Vysioneer and receives research funding from Genentech.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This observational study was not considered human subject research and received exemption from Institutional Review Board approval at our institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}